undefined
EUTM file information

018445294

MEDICAGO UNLEASH THE POWER OF PLANTS


April 1, 2021

Trademark Summary

The trademark application MEDICAGO UNLEASH THE POWER OF PLANTS was filed by Medicago inc., a corporation established under the laws of Canada (the "Applicant"). The application was published for oppositions on May 4, 2021, and it was registered by office on August 11, 2021 without any oppositions.

The application was filed in English (French was selected as the second language).

Change of name and address of the trademark registration was recorded on January 8, 2024.


Goods And Services

  • The mark was filed in class 5 with Pharmaceutical and medicinal preparations and substances, namely, human vaccines, therapeutic proteins and antibodies for the treatment of infectious diseases, chronic diseases and cancer..
  • The mark was filed in class 40 with Manufacture of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies for others and Custom manufacturing of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies...
  • The mark was filed in class 42 with following description of goods:
    1. Research and development in the field of human vaccines, recombinant proteins and antibodies for therapeutic and prophylactic use
    2. High-throughput vaccine engineering services
    3. Medical and scientific research services of proprietary recombinant protein platform technologies designed to lead to new human vaccines, therapeutic proteins and antibodies
    4. Product research and development and scientific research, all in the field of protein production using recombinant technologies through transient expression in plants
    5. Medical and scientific research services relating to infectious diseases
    6. Development of new products for others in the field of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies
    7. Medical and scientific research regarding clinical trial studies on new vaccine candidates..
  • The mark was filed in class 44 with Medical information services, namely, providing information to physicians, healthcare professionals and patients on the topics of health issues, health awareness, diagnostic, prophylactic and therapeutic properties of vaccines, recombinant proteins and antibodies and On-line information services, namely, providing information to physicians, healthcare professionals and patients on the topics of health issues, health awareness, diagnostic, prophylactic and therapeutic properties of vaccines, recombinant proteins and antibodies...